Investigating the Pharmacokinetics, Safety and Tolerability After a Single Subcutaneous Injection of Semaglutide in Subjects With Mild, Moderate or Severe Hepatic Impairment Compared to Subjects With Normal Hepatic Function
Clinical trial NCT02210871 · COMPLETED
Trial details
- NCT number
- NCT02210871
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-08-07
- Primary completion
- 2015-06-03
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.